Filing Details

Accession Number:
0001181431-14-034523
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-20 20:08:28
Reporting Period:
2014-10-16
Filing Date:
2014-10-20
Accepted Time:
2014-10-20 20:08:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Commercial Physical & Biological Research (8731) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216274 Peter Graham Lidgard C/O Exact Sciences Corp.
441 Charmany Drive
Madison WI 53719
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-16 50,000 $2.88 167,783 No 4 M Direct
Common Stock Disposition 2014-10-16 50,000 $22.84 117,783 No 4 S Direct
Common Stock Acquisiton 2014-10-17 50,000 $2.88 167,783 No 4 M Direct
Common Stock Disposition 2014-10-17 50,000 $23.68 117,783 No 4 S Direct
Common Stock Acquisiton 2014-10-20 50,000 $2.88 167,783 No 4 M Direct
Common Stock Disposition 2014-10-20 50,000 $23.93 117,783 No 4 S Direct
Common Stock Acquisiton 2014-10-20 75,000 $2.88 192,783 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-10-16 50,000 $0.00 600,000 $2.88
Common Stock Stock Option (right to buy) Disposition 2014-10-17 50,000 $0.00 550,000 $2.88
Common Stock Stock Option (right to buy) Disposition 2014-10-20 50,000 $0.00 500,000 $2.88
Common Stock Stock Option (right to buy) Disposition 2014-10-20 75,000 $0.00 450,000 $2.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
550,000 2013-08-03 2019-08-03 No 4 M Direct
500,000 2013-08-03 2019-08-03 No 4 M Direct
450,000 2013-08-03 2019-08-03 No 4 M Direct
375,000 2013-08-03 2019-08-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,395 Indirect Held in 401(K) Account
Footnotes
  1. The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares pursuant to this 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.